Global Flunixin Meglumine Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 226232
  • calendar_today Published On: Jun, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Flunixin Meglumine Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Flunixin Meglumine Injection size is estimated to be XX million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Flunixin Meglumine Injection market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Flunixin Meglumine Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

10ml/Dose

20ml/ Dose

Market segment by Application can be divided into

Animal muscle pain

Animal febrile disease

Others

The key market players for global Flunixin Meglumine Injection market are listed below:

Norbrook

Zoteis

Merck Animal Health

Virbac Animal Health India Private Limited

MSD Animal Health

Bengal Remedies Limited

Wuhan Huisheng Biological Technology Co., Ltd.

Qilu Animal Health Products Co., Ltd.

Baimukang Animal Pharmaceutical Co., Ltd.

Shandong Zhongmu Veterinary Medicine Co., Ltd.

Hebei New Century Pharmaceutical Co., Ltd.

Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd.

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Flunixin Meglumine Injection product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Flunixin Meglumine Injection, with price, sales, revenue and global market share of Flunixin Meglumine Injection from 2019 to 2021.

Chapter 3, the Flunixin Meglumine Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Flunixin Meglumine Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Flunixin Meglumine Injection market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Flunixin Meglumine Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Flunixin Meglumine Injection Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Flunixin Meglumine Injection Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 10ml/Dose

1.2.3 20ml/ Dose

1.3 Market Analysis by Application

1.3.1 Overview: Global Flunixin Meglumine Injection Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Animal muscle pain

1.3.3 Animal febrile disease

1.3.4 Others

1.4 Global Flunixin Meglumine Injection Market Size & Forecast

1.4.1 Global Flunixin Meglumine Injection Sales in Value (2016-2026))

1.4.2 Global Flunixin Meglumine Injection Sales in Volume (2016-2026)

1.4.3 Global Flunixin Meglumine Injection Price by Type (2016-2026) & (US$/Dose)

1.5 Global Flunixin Meglumine Injection Production Capacity Analysis

1.5.1 Global Flunixin Meglumine Injection Total Production Capacity (2016-2026)

1.5.2 Global Flunixin Meglumine Injection Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Flunixin Meglumine Injection Market Drivers

1.6.2 Flunixin Meglumine Injection Market Restraints

1.6.3 Flunixin Meglumine Injection Trends Analysis

2 Manufacturers Profiles

2.1 Norbrook

2.1.1 Norbrook Details

2.1.2 Norbrook Major Business

2.1.3 Norbrook Flunixin Meglumine Injection Product and Services

2.1.4 Norbrook Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Zoteis

2.2.1 Zoteis Details

2.2.2 Zoteis Major Business

2.2.3 Zoteis Flunixin Meglumine Injection Product and Services

2.2.4 Zoteis Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Merck Animal Health

2.3.1 Merck Animal Health Details

2.3.2 Merck Animal Health Major Business

2.3.3 Merck Animal Health Flunixin Meglumine Injection Product and Services

2.3.4 Merck Animal Health Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Virbac Animal Health India Private Limited

2.4.1 Virbac Animal Health India Private Limited Details

2.4.2 Virbac Animal Health India Private Limited Major Business

2.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product and Services

2.4.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 MSD Animal Health

2.5.1 MSD Animal Health Details

2.5.2 MSD Animal Health Major Business

2.5.3 MSD Animal Health Flunixin Meglumine Injection Product and Services

2.5.4 MSD Animal Health Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Bengal Remedies Limited

2.6.1 Bengal Remedies Limited Details

2.6.2 Bengal Remedies Limited Major Business

2.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Product and Services

2.6.4 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Wuhan Huisheng Biological Technology Co., Ltd.

2.7.1 Wuhan Huisheng Biological Technology Co., Ltd. Details

2.7.2 Wuhan Huisheng Biological Technology Co., Ltd. Major Business

2.7.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product and Services

2.7.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Qilu Animal Health Products Co., Ltd.

2.8.1 Qilu Animal Health Products Co., Ltd. Details

2.8.2 Qilu Animal Health Products Co., Ltd. Major Business

2.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product and Services

2.8.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Baimukang Animal Pharmaceutical Co., Ltd.

2.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Details

2.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Major Business

2.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services

2.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.

2.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Details

2.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Major Business

2.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product and Services

2.10.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Hebei New Century Pharmaceutical Co., Ltd.

2.11.1 Hebei New Century Pharmaceutical Co., Ltd. Details

2.11.2 Hebei New Century Pharmaceutical Co., Ltd. Major Business

2.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services

2.11.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.

2.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Details

2.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Major Business

2.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services

2.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Shandong Lukang Pharmaceutical Co., Ltd.

2.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Details

2.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Major Business

2.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services

2.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Flunixin Meglumine Injection Sales by Manufacturer

3.1 Global Flunixin Meglumine Injection Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Flunixin Meglumine Injection Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Flunixin Meglumine Injection

3.4 Market Concentration Rate

3.4.1 Top 3 Flunixin Meglumine Injection Manufacturer Market Share

3.4.2 Top 6 Flunixin Meglumine Injection Manufacturer Market Share

3.5 Global Flunixin Meglumine Injection Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Flunixin Meglumine Injection Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Flunixin Meglumine Injection Market Size by Region

4.1.1 Global Flunixin Meglumine Injection Sales in Volume by Region (2016-2026)

4.1.2 Global Flunixin Meglumine Injection Revenue by Region (2016-2026)

4.2 North America Flunixin Meglumine Injection Revenue (2016-2026)

4.3 Europe Flunixin Meglumine Injection Revenue (2016-2026)

4.4 Asia-Pacific Flunixin Meglumine Injection Revenue (2016-2026)

4.5 South America Flunixin Meglumine Injection Revenue (2016-2026)

4.6 Middle East and Africa Flunixin Meglumine Injection Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Flunixin Meglumine Injection Sales in Volume by Type (2016-2026)

5.2 Global Flunixin Meglumine Injection Revenue by Type (2016-2026)

5.3 Global Flunixin Meglumine Injection Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Flunixin Meglumine Injection Sales in Volume by Application (2016-2026)

6.2 Global Flunixin Meglumine Injection Revenue by Application (2016-2026)

6.3 Global Flunixin Meglumine Injection Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Flunixin Meglumine Injection Sales by Type (2016-2026)

7.2 North America Flunixin Meglumine Injection Sales by Application (2016-2026)

7.3 North America Flunixin Meglumine Injection Market Size by Country

7.3.1 North America Flunixin Meglumine Injection Sales in Volume by Country (2016-2026)

7.3.2 North America Flunixin Meglumine Injection Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Flunixin Meglumine Injection Sales by Type (2016-2026)

8.2 Europe Flunixin Meglumine Injection Sales by Application (2016-2026)

8.3 Europe Flunixin Meglumine Injection Market Size by Country

8.3.1 Europe Flunixin Meglumine Injection Sales in Volume by Country (2016-2026)

8.3.2 Europe Flunixin Meglumine Injection Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Flunixin Meglumine Injection Sales by Type (2016-2026)

9.2 Asia-Pacific Flunixin Meglumine Injection Sales by Application (2016-2026)

9.3 Asia-Pacific Flunixin Meglumine Injection Market Size by Region

9.3.1 Asia-Pacific Flunixin Meglumine Injection Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Flunixin Meglumine Injection Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Flunixin Meglumine Injection Sales by Type (2016-2026)

10.2 South America Flunixin Meglumine Injection Sales by Application (2016-2026)

10.3 South America Flunixin Meglumine Injection Market Size by Country

10.3.1 South America Flunixin Meglumine Injection Sales in Volume by Country (2016-2026)

10.3.2 South America Flunixin Meglumine Injection Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Flunixin Meglumine Injection Sales by Type (2016-2026)

11.2 Middle East & Africa Flunixin Meglumine Injection Sales by Application (2016-2026)

11.3 Middle East & Africa Flunixin Meglumine Injection Market Size by Country

11.3.1 Middle East & Africa Flunixin Meglumine Injection Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Flunixin Meglumine Injection Typical Distributors

12.3 Flunixin Meglumine Injection Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Flunixin Meglumine Injection Revenue by Type, (USD Million), 2021-2026

Table 2. Global Flunixin Meglumine Injection Revenue by Application, (USD Million), 2021-2026

Table 3. Norbrook Basic Information, Manufacturing Base and Competitors

Table 4. Norbrook Major Business

Table 5. Norbrook Flunixin Meglumine Injection Product and Services

Table 6. Norbrook Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Zoteis Basic Information, Manufacturing Base and Competitors

Table 8. Zoteis Major Business

Table 9. Zoteis Flunixin Meglumine Injection Product and Services

Table 10. Zoteis Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Merck Animal Health Basic Information, Manufacturing Base and Competitors

Table 12. Merck Animal Health Major Business

Table 13. Merck Animal Health Flunixin Meglumine Injection Product and Services

Table 14. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Virbac Animal Health India Private Limited Basic Information, Manufacturing Base and Competitors

Table 16. Virbac Animal Health India Private Limited Major Business

Table 17. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product and Services

Table 18. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. MSD Animal Health Basic Information, Manufacturing Base and Competitors

Table 20. MSD Animal Health Major Business

Table 21. MSD Animal Health Flunixin Meglumine Injection Product and Services

Table 22. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Bengal Remedies Limited Basic Information, Manufacturing Base and Competitors

Table 24. Bengal Remedies Limited Major Business

Table 25. Bengal Remedies Limited Flunixin Meglumine Injection Product and Services

Table 26. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Wuhan Huisheng Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors

Table 28. Wuhan Huisheng Biological Technology Co., Ltd. Major Business

Table 29. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product and Services

Table 30. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Qilu Animal Health Products Co., Ltd. Basic Information, Manufacturing Base and Competitors

Table 32. Qilu Animal Health Products Co., Ltd. Major Business

Table 33. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product and Services

Table 34. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Baimukang Animal Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors

Table 36. Baimukang Animal Pharmaceutical Co., Ltd. Major Business

Table 37. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services

Table 38. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Shandong Zhongmu Veterinary Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors

Table 40. Shandong Zhongmu Veterinary Medicine Co., Ltd. Major Business

Table 41. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product and Services

Table 42. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Hebei New Century Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors

Table 44. Hebei New Century Pharmaceutical Co., Ltd. Major Business

Table 45. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services

Table 46. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors

Table 48. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Major Business

Table 49. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services

Table 50. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Shandong Lukang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors

Table 52. Shandong Lukang Pharmaceutical Co., Ltd. Major Business

Table 53. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services

Table 54. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Global Flunixin Meglumine Injection Sales by Manufacturer (2019-2021e) & (K Doses)

Table 56. Global Flunixin Meglumine Injection Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 57. Market Position of Manufacturers in Flunixin Meglumine Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 58. Global Flunixin Meglumine Injection Production Capacity by Company, (K Doses): 2020 VS 2021

Table 59. Head Office and Flunixin Meglumine Injection Production Site of Key Manufacturer

Table 60. Flunixin Meglumine Injection New Entrant and Capacity Expansion Plans

Table 61. Flunixin Meglumine Injection Mergers & Acquisitions in the Past Five Years

Table 62. Global Flunixin Meglumine Injection Sales by Region (2016-2021e) & (K Doses)

Table 63. Global Flunixin Meglumine Injection Sales by Region (2021-2026) & (K Doses)

Table 64. Global Flunixin Meglumine Injection Revenue by Region (2016-2021e) & (USD Million)

Table 65. Global Flunixin Meglumine Injection Revenue by Region (2021-2026) & (USD Million)

Table 66. Global Flunixin Meglumine Injection Sales by Type (2016-2021e) & (K Doses)

Table 67. Global Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses)

Table 68. Global Flunixin Meglumine Injection Revenue by Type (2016-2021e) & (USD Million)

Table 69. Global Flunixin Meglumine Injection Revenue by Type (2021-2026) & (USD Million)

Table 70. Global Flunixin Meglumine Injection Price by Type (2016-2021e) & (US$/Dose)

Table 71. Global Flunixin Meglumine Injection Price by Type (2021-2026) & (US$/Dose)

Table 72. Global Flunixin Meglumine Injection Sales by Application (2016-2021e) & (K Doses)

Table 73. Global Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses)

Table 74. Global Flunixin Meglumine Injection Revenue by Application (2016-2021e) & (USD Million)

Table 75. Global Flunixin Meglumine Injection Revenue by Application (2021-2026) & (USD Million)

Table 76. Global Flunixin Meglumine Injection Price by Application (2016-2021e) & (US$/Dose)

Table 77. Global Flunixin Meglumine Injection Price by Application (2021-2026) & (US$/Dose)

Table 78. North America Flunixin Meglumine Injection Sales by Country (2016-2021e) & (K Doses)

Table 79. North America Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses)

Table 80. North America Flunixin Meglumine Injection Revenue by Country (2016-2021e) & (USD Million)

Table 81. North America Flunixin Meglumine Injection Revenue by Country (2021-2026) & (USD Million)

Table 82. North America Flunixin Meglumine Injection Sales by Type (2016-2021e) & (K Doses)

Table 83. North America Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses)

Table 84. North America Flunixin Meglumine Injection Sales by Application (2016-2021e) & (K Doses)

Table 85. North America Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses)

Table 86. Europe Flunixin Meglumine Injection Sales by Country (2016-2021e) & (K Doses)

Table 87. Europe Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses)

Table 88. Europe Flunixin Meglumine Injection Revenue by Country (2016-2021e) & (USD Million)

Table 89. Europe Flunixin Meglumine Injection Revenue by Country (2021-2026) & (USD Million)

Table 90. Europe Flunixin Meglumine Injection Sales by Type (2016-2021e) & (K Doses)

Table 91. Europe Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses)

Table 92. Europe Flunixin Meglumine Injection Sales by Application (2016-2021e) & (K Doses)

Table 93. Europe Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses)

Table 94. Asia-Pacific Flunixin Meglumine Injection Sales by Region (2016-2021e) & (K Doses)

Table 95. Asia-Pacific Flunixin Meglumine Injection Sales by Region (2021-2026) & (K Doses)

Table 96. Asia-Pacific Flunixin Meglumine Injection Revenue by Region (2016-2021e) & (USD Million)

Table 97. Asia-Pacific Flunixin Meglumine Injection Revenue by Region (2021-2026) & (USD Million)

Table 98. Asia-Pacific Flunixin Meglumine Injection Sales by Type (2016-2021e) & (K Doses)

Table 99. Asia-Pacific Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses)

Table 100. Asia-Pacific Flunixin Meglumine Injection Sales by Application (2016-2021e) & (K Doses)

Table 101. Asia-Pacific Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses)

Table 102. South America Flunixin Meglumine Injection Sales by Country (2016-2021e) & (K Doses)

Table 103. South America Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses)

Table 104. South America Flunixin Meglumine Injection Revenue by Country (2016-2021e) & (USD Million)

Table 105. South America Flunixin Meglumine Injection Revenue by Country (2021-2026) & (USD Million)

Table 106. South America Flunixin Meglumine Injection Sales by Type (2016-2021e) & (K Doses)

Table 107. South America Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses)

Table 108. South America Flunixin Meglumine Injection Sales by Application (2016-2021e) & (K Doses)

Table 109. South America Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses)

Table 110. Middle East & Africa Flunixin Meglumine Injection Sales by Country (2016-2021e) & (K Doses)

Table 111. Middle East & Africa Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses)

Table 112. Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2016-2021e) & (USD Million)

Table 113. Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2021-2026) & (USD Million)

Table 114. Middle East & Africa Flunixin Meglumine Injection Sales by Type (2016-2021e) & (K Doses)

Table 115. Middle East & Africa Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses)

Table 116. Middle East & Africa Flunixin Meglumine Injection Sales by Application (2016-2021e) & (K Doses)

Table 117. Middle East & Africa Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses)

Table 118. Direct Channel Pros & Cons

Table 119. Indirect Channel Pros & Cons

Table 120. Flunixin Meglumine Injection Typical Distributors

Table 121. Flunixin Meglumine Injection Typical Customers

List of Figures

Figure 1. Flunixin Meglumine Injection Picture

Figure 2. Global Flunixin Meglumine Injection Sales Market Share by Type in 2020

Figure 3. 10ml/Dose

Figure 4. 20ml/ Dose

Figure 5. Global Flunixin Meglumine Injection Sales Market Share by Application in 2020

Figure 6. Animal muscle pain

Figure 7. Animal febrile disease

Figure 8. Others

Figure 9. Global Flunixin Meglumine Injection Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026

Figure 10. Global Flunixin Meglumine Injection Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Flunixin Meglumine Injection Sales (2016-2026) & (K Doses)

Figure 12. Global Flunixin Meglumine Injection Price by Type (2016-2026) & (US$/Dose)

Figure 13. Global Flunixin Meglumine Injection Production Capacity (2016-2026) & (K Doses)

Figure 14. Global Flunixin Meglumine Injection Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Flunixin Meglumine Injection Market Drivers

Figure 16. Flunixin Meglumine Injection Market Restraints

Figure 17. Flunixin Meglumine Injection Market Trends

Figure 18. Global Flunixin Meglumine Injection Sales Market Share by Manufacturer in 2020

Figure 19. Global Flunixin Meglumine Injection Revenue Market Share by Manufacturer in 2020

Figure 20. Flunixin Meglumine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Flunixin Meglumine Injection Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Flunixin Meglumine Injection Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Flunixin Meglumine Injection Sales Market Share by Region (2016-2026)

Figure 24. Global Flunixin Meglumine Injection Revenue Market Share by Region (2016-2026)

Figure 25. North America Flunixin Meglumine Injection Revenue (2016-2026) & (USD Million)

Figure 26. Europe Flunixin Meglumine Injection Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Flunixin Meglumine Injection Revenue (2016-2026) & (USD Million)

Figure 28. South America Flunixin Meglumine Injection Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Flunixin Meglumine Injection Revenue (2016-2026) & (USD Million)

Figure 30. Global Flunixin Meglumine Injection Sales Market Share by Type (2016-2026)

Figure 31. Global Flunixin Meglumine Injection Revenue Market Share by Type (2016-2026)

Figure 32. Global Flunixin Meglumine Injection Price by Type (2016-2026) & (US$/Dose)

Figure 33. Global Flunixin Meglumine Injection Sales Market Share by Application (2016-2026)

Figure 34. Global Flunixin Meglumine Injection Revenue Market Share by Application (2016-2026)

Figure 35. Global Flunixin Meglumine Injection Price by Application (2016-2026) & (US$/Dose)

Figure 36. North America Flunixin Meglumine Injection Sales Market Share by Type (2016-2026)

Figure 37. North America Flunixin Meglumine Injection Sales Market Share by Application (2016-2026)

Figure 38. North America Flunixin Meglumine Injection Sales Market Share by Country (2016-2026)

Figure 39. North America Flunixin Meglumine Injection Revenue Market Share by Country (2016-2026)

Figure 40. United States Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Flunixin Meglumine Injection Sales Market Share by Type (2016-2026)

Figure 44. Europe Flunixin Meglumine Injection Sales Market Share by Application (2016-2026)

Figure 45. Europe Flunixin Meglumine Injection Sales Market Share by Country (2016-2026)

Figure 46. Europe Flunixin Meglumine Injection Revenue Market Share by Country (2016-2026)

Figure 47. Germany Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Flunixin Meglumine Injection Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Flunixin Meglumine Injection Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Flunixin Meglumine Injection Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Flunixin Meglumine Injection Revenue Market Share by Region (2016-2026)

Figure 56. China Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Flunixin Meglumine Injection Sales Market Share by Type (2016-2026)

Figure 63. South America Flunixin Meglumine Injection Sales Market Share by Application (2016-2026)

Figure 64. South America Flunixin Meglumine Injection Sales Market Share by Country (2016-2026)

Figure 65. South America Flunixin Meglumine Injection Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Flunixin Meglumine Injection Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Flunixin Meglumine Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source